Laiyifen set up a business development company including integrated circuit business. The enterprise search APP shows that recently, Shanghai Laiyifen Future Domain Business Development Co., Ltd. was established, with the legal representative of Yu Ruifen and the registered capital of 1 million yuan. Its business scope includes: the second type of value-added telecommunications business; Internet information service; Communication equipment sales; Integrated circuit chips and product sales; Integrated circuit sales, etc. Enterprise investigation shows that the company is wholly owned by Laiyi.People's Government of Minhang District, Shanghai: Helping enterprises to go out and encourage foreign trade enterprises to expand their business. The People's Government of Minhang District issued the Policy Opinions on High-quality Industrial Development in Minhang District (Trial), which pointed out that helping enterprises to go out. Support enterprises to purchase export credit insurance products and build or rent overseas warehouses overseas. Encourage foreign trade enterprises to expand their business and give certain financial support to enterprises that reach a certain scale. Support new energy vehicles, used cars, photovoltaics and other enterprises to expand overseas markets. Support the development of cross-border e-commerce. Support the development, maintenance and system construction of enterprises to build or dock cross-border e-commerce platforms. Encourage enterprises to export business in cross-border e-commerce mode. Encourage enterprises to deeply participate in the creation of the "Silk Road E-commerce" cooperation pioneer zone.The turnover of Shanghai, Shenzhen and Beijing exceeded 1 trillion yuan, 15.6 billion yuan more than the previous day. Up to now, the turnover of Shanghai, Shenzhen and Beijing exceeded 1 trillion yuan, 15.6 billion yuan more than the previous day. Among them, the turnover of Shanghai Stock Exchange was 378.3 billion yuan, that of Shenzhen Stock Exchange was 611.9 billion yuan, and that of Beizheng 50 was 10.5 billion yuan.
Genting Xinyao: The first prescription of itramod in Macau, China officially benefited Asian patients. Genting Xinyao announced that its first prescription of itramod was made in Jinghu Hospital in Macau, China on December 11th, which was the first prescription made by itramod after it was approved in Genting Xinyao Asia Authorized Zone, marking that this heavy product in the field of autoimmune diseases officially began to benefit Asian patients. Luo Yongqing, CEO of Genting Xinyao, said that the arrival of the first prescription of Ithmod in China and Macau was another milestone in the commercialization of Genting Xinyao. By 2030, the number of patients with ulcerative colitis in China is expected to more than double that in 2019, reaching about 1 million. There is a huge unmet demand for innovative therapies. Following the approval in Macau in April this year, Iturmod, as the third commercial new drug of Genting Xinyao, will bring new treatment options to more patients with ulcerative colitis.The turnover of Shanghai and Shenzhen stock markets exceeded 1 trillion for the 52nd consecutive trading day, exceeding 10 billion compared with yesterday.Zou Yingguang, General Manager of CITIC Securities: It is expected that the demand for cross-border investment and financing at home and abroad will be further released. At the investor open day of CITIC Securities in 2024, Zou Yingguang, General Manager of CITIC Securities, said that the demand for two-way cross-border investment and financing is very strong, whether it is a China enterprise "going abroad" or an overseas investor "coming to China". Among them, with the rapid evolution of China's new open economic system, cross-border finance will usher in greater development space, and securities companies will be in cross-border finance. In the medium and long term, China's macro securitization rate is still accelerating, the internationalization of Chinese-funded enterprises will continue to increase, and the opening up of China's capital market will continue to increase. It is expected that the demand for cross-border investment and financing from domestic and foreign customers will be further released.
The liquor sector moved up, Tianyoude Liquor rose daily, Gujing Distillery rose by more than 4%, and Huangtai Liquor, Shunxin Agriculture, Laobaigan Liquor and Yilite followed suit.The Hang Seng Index rose more than 1%, the Hang Seng Technology Index rose 1.47%, and the technology stocks strengthened.Meitu, a Hong Kong stock company, rose more than 10% in intraday trading, with turnover exceeding HK$ 400 million.
Strategy guide 12-13
Strategy guide
12-13
Strategy guide
12-13
Strategy guide